CHAPTER 1. METHODOLOGY AND SCOPE
1.1. MARKET SEGMENTATION & SCOPE
1.1.1. PRODUCT
1.1.2. ASSAY
1.1.3. APPLICATION
1.2. RESEARCH METHODOLOGY
1.3. INFORMATION PROCUREMENT
1.3.1. PURCHASED DATABASE
1.3.2. GVR’S INTERNAL DATABASE
1.3.3. SECONDARY SOURCES
1.3.4. PRIMARY RESEARCH
1.3.5. DETAILS OF PRIMARY RESEARCH
1.4. INFORMATION OR DATA ANALYSIS
1.4.1. DATA ANALYSIS MODELS
1.5. MARKET FORMULATION & VALIDATION
1.6. MODEL DETAILS
1.7. LIST OF SECONDARY SOURCES
1.8. LIST OF PRIMARY SOURCES
1.9. OBJECTIVES
1.9.1. OBJECTIVE 1
1.9.2. OBJECTIVE 2
CHAPTER 2. EXECUTIVE SUMMARY
2.1. MARKET OUTLOOK
2.2. SEGMENT OUTLOOK
2.3. COMPETITIVE INSIGHTS
CHAPTER 3. G-PROTEIN COUPLED RECEPTORS MARKET VARIABLES AND TRENDS
3.1. MARKET LINEAGE OUTLOOK
3.1.1. PARENT MARKET OUTLOOK
3.1.2. RELATED/ANCILLARY MARKET OUTLOOK
3.2. MARKET DYNAMICS
3.2.1. MARKET DRIVER ANALYSIS
3.2.2. MARKET RESTRAINT ANALYSIS
3.3. INDUSTRY ANALYSIS TOOLS
3.3.1. INDUSTRY ANALYSIS - PORTER’S
3.3.2. PESTEL ANALYSIS
3.3.3. COVID-19 IMPACT ANALYSIS
CHAPTER 4. G-PROTEIN COUPLED RECEPTORS MARKET : BY PRODUCT ESTIMATES & TREND ANALYSIS
4.1. PRODUCT SEGMENT DASHBOARD
4.2. G-PROTEIN COUPLED RECEPTORS MARKET: PRODUCT MOVEMENT ANALYSIS
4.3. G-PROTEIN COUPLED RECEPTORS MARKET SIZE & TREND ANALYSIS, BY PRODUCT, 2025 TO 2033
4.4. CELL LINES
4.4.1. CELL LINES MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
4.5. DETECTION KITS
4.5.1. DETECTION KITS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
4.6. CELL CULTURE REAGENTS
4.6.1. CELL CULTURE REAGENTS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
4.7. LIGANDS
4.7.1. LIGANDS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
CHAPTER 5. G-PROTEIN COUPLED RECEPTORS MARKET : BY ASSAY TYPE ESTIMATES & TREND ANALYSIS
5.1. ASSAY SEGMENT DASHBOARD
5.2. G-PROTEIN COUPLED RECEPTORS MARKET: ASSAY MOVEMENT ANALYSIS
5.3. G-PROTEIN COUPLED RECEPTORS MARKET SIZE & TREND ANALYSIS, BY ASSAY, 2025 TO 2033
5.4. CAMP FUNCTIONAL ASSAYS
5.4.1. CAMP FUNCTIONAL ASSAYS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
5.5. CALCIUM FUNCTIONAL ASSAYS
5.5.1. CALCIUM FUNCTIONAL ASSAYS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
5.6. Β-ARRESTIN FUNCTIONAL ASSAYS
5.6.1. Β-ARRESTIN FUNCTIONAL ASSAYS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
5.7. RADIOLIGAND BINDING AND GTPΓS FUNCTIONAL ASSAYS
5.7.1. RADIOLIGAND BINDING AND GTPΓS FUNCTIONAL ASSAYS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
5.8. INTERNATIONALIZATION ASSAYS
5.8.1. INTERNATIONALIZATION ASSAYS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
5.9. TRAFFICKING ASSAYS
5.9.1. TRAFFICKING ASSAYS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
5.10. OTHER ASSAYS
5.10.1. OTHER ASSAYS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
CHAPTER 6. G-PROTEIN COUPLED RECEPTORS MARKET : BY APPLICATION ESTIMATES & TREND ANALYSIS
6.1. APPLICATION SEGMENT DASHBOARD
6.2. G-PROTEIN COUPLED RECEPTORS MARKET: APPLICATION MOVEMENT ANALYSIS
6.3. G-PROTEIN COUPLED RECEPTORS MARKET SIZE & TREND ANALYSIS, BY APPLICATION, 2025 TO 2033
6.4. CANCER RESEARCH
6.4.1. CANCER RESEARCH MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
6.5. CNS RESEARCH
6.5.1. CNS RESEARCH MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
6.6. METABOLIC RESEARCH
6.6.1. METABOLIC RESEARCH MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
6.7. CARDIOVASCULAR RESEARCH
6.7.1. CARDIOVASCULAR RESEARCH MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
6.8. INFLAMMATION RESEARCH
6.8.1. INFLAMMATION RESEARCH MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
6.9. RESPIRATORY RESEARCH
6.9.1. RESPIRATORY RESEARCH MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
6.10. OTHER APPLICATIONS
6.10.1. OTHER APPLICATIONS MARKET ESTIMATES AND FORECASTS, 2025 TO 2033
CHAPTER 7. G-PROTEIN COUPLED RECEPTORS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. REGIONAL MARKET DASHBOARD
7.2. REGIONAL MARKET SHARE ANALYSIS, 2024 & 2030
7.3. G-PROTEIN COUPLED RECEPTORS MARKET BY REGION: KEY TAKEAWAYS
7.4. NORTH AMERICA
7.4.1. NORTH AMERICA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.4.2. U.S.
7.4.2.1. KEY COUNTRY DYNAMICS
7.4.2.2. COMPETITIVE SCENARIO
7.4.2.3. U.S. MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.4.3. CANADA
7.4.3.1. KEY COUNTRY DYNAMICS
7.4.3.2. COMPETITIVE SCENARIO
7.4.3.3. CANADA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.4.4. MEXICO
7.4.4.1. KEY COUNTRY DYNAMICS
7.4.4.2. COMPETITIVE SCENARIO
7.4.4.3. MEXICO MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5. EUROPE
7.5.1. EUROPE MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.2. UK
7.5.2.1. KEY COUNTRY DYNAMICS
7.5.2.2. COMPETITIVE SCENARIO
7.5.2.3. UK MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.3. GERMANY
7.5.3.1. KEY COUNTRY DYNAMICS
7.5.3.2. COMPETITIVE SCENARIO
7.5.3.3. GERMANY MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.4. FRANCE
7.5.4.1. KEY COUNTRY DYNAMICS
7.5.4.2. COMPETITIVE SCENARIO
7.5.4.3. FRANCE MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.5. ITALY
7.5.5.1. KEY COUNTRY DYNAMICS
7.5.5.2. COMPETITIVE SCENARIO
7.5.5.3. ITALY MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.6. SPAIN
7.5.6.1. KEY COUNTRY DYNAMICS
7.5.6.2. COMPETITIVE SCENARIO
7.5.6.3. SPAIN MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.7. SWEDEN
7.5.7.1. KEY COUNTRY DYNAMICS
7.5.7.2. COMPETITIVE SCENARIO
7.5.7.3. SWEDEN MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.8. NORWAY
7.5.8.1. KEY COUNTRY DYNAMICS
7.5.8.2. COMPETITIVE SCENARIO
7.5.8.3. NORWAY MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.5.9. DENMARK
7.5.9.1. KEY COUNTRY DYNAMICS
7.5.9.2. COMPETITIVE SCENARIO
7.5.9.3. DENMARK MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.6. ASIA PACIFIC
7.6.1. ASIA PACIFIC MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.6.2. JAPAN
7.6.2.1. KEY COUNTRY DYNAMICS
7.6.2.2. COMPETITIVE SCENARIO
7.6.2.3. JAPAN MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.6.3. CHINA
7.6.3.1. KEY COUNTRY DYNAMICS
7.6.3.2. COMPETITIVE SCENARIO
7.6.3.3. CHINA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.6.4. INDIA
7.6.4.1. KEY COUNTRY DYNAMICS
7.6.4.2. COMPETITIVE SCENARIO
7.6.4.3. INDIA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.6.5. AUSTRALIA
7.6.5.1. KEY COUNTRY DYNAMICS
7.6.5.2. COMPETITIVE SCENARIO
7.6.5.3. AUSTRALIA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.6.6. THAILAND
7.6.6.1. KEY COUNTRY DYNAMICS
7.6.6.2. COMPETITIVE SCENARIO
7.6.6.3. THAILAND MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.6.7. SOUTH KOREA
7.6.7.1. KEY COUNTRY DYNAMICS
7.6.7.2. COMPETITIVE SCENARIO
7.6.7.3. SOUTH KOREA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.7. LATIN AMERICA
7.7.1. LATIN AMERICA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.7.2. BRAZIL
7.7.2.1. KEY COUNTRY DYNAMICS
7.7.2.2. COMPETITIVE SCENARIO
7.7.2.3. BRAZIL MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.7.3. ARGENTINA
7.7.3.1. KEY COUNTRY DYNAMICS
7.7.3.2. COMPETITIVE SCENARIO
7.7.3.3. ARGENTINA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.8. MEA
7.8.1. MEA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.8.2. SAUDI ARABIA
7.8.2.1. KEY COUNTRY DYNAMICS
7.8.2.2. COMPETITIVE SCENARIO
7.8.2.3. SAUDI ARABIA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.8.3. SOUTH AFRICA
7.8.3.1. KEY COUNTRY DYNAMICS
7.8.3.2. COMPETITIVE SCENARIO
7.8.3.3. SOUTH AFRICA MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.8.4. UAE
7.8.4.1. KEY COUNTRY DYNAMICS
7.8.4.2. COMPETITIVE SCENARIO
7.8.4.3. UAE MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
7.8.5. KUWAIT
7.8.5.1. KEY COUNTRY DYNAMICS
7.8.5.2. COMPETITIVE SCENARIO
7.8.5.3. KUWAIT MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (REVENUE, USD MILLION)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. PARTICIPANT CATEGORIZATION
8.2. COMPANY MARKET POSITION ANALYSIS, 2024
8.3. PARTICIPANT OVERVIEW
8.3.1. THERMO FISHER SCIENTIFIC INC.
8.3.1.1. COMPANY OVERVIEW
8.3.1.2. FINANCIAL PERFORMANCE
8.3.1.3. PRODUCT BENCHMARKING
8.3.1.4. STRATEGIC INITIATIVES
8.3.2. EUROFINS SCIENTIFIC
8.3.2.1. COMPANY OVERVIEW
8.3.2.2. FINANCIAL PERFORMANCE
8.3.2.3. PRODUCT BENCHMARKING
8.3.2.4. STRATEGIC INITIATIVES
8.3.3. QIAGEN
8.3.3.1. COMPANY OVERVIEW
8.3.3.2. FINANCIAL PERFORMANCE
8.3.3.3. PRODUCT BENCHMARKING
8.3.3.4. STRATEGIC INITIATIVES
8.3.4. WUXI APPTEC
8.3.4.1. COMPANY OVERVIEW
8.3.4.2. FINANCIAL PERFORMANCE
8.3.4.3. PRODUCT BENCHMARKING
8.3.4.4. STRATEGIC INITIATIVES
8.3.5. PROMEGA CORPORATION
8.3.5.1. COMPANY OVERVIEW
8.3.5.2. FINANCIAL PERFORMANCE
8.3.5.3. PRODUCT BENCHMARKING
8.3.5.4. STRATEGIC INITIATIVES
8.3.6. ABCAM PLC
8.3.6.1. COMPANY OVERVIEW
8.3.6.2. FINANCIAL PERFORMANCE
8.3.6.3. PRODUCT BENCHMARKING
8.3.6.4. STRATEGIC INITIATIVES
8.3.7. MERCK KGAA
8.3.7.1. COMPANY OVERVIEW
8.3.7.2. FINANCIAL PERFORMANCE
8.3.7.3. PRODUCT BENCHMARKING
8.3.7.4. STRATEGIC INITIATIVES
8.3.8. PERKINELMER INC.
8.3.8.1. COMPANY OVERVIEW
8.3.8.2. FINANCIAL PERFORMANCE
8.3.8.3. PRODUCT BENCHMARKING
8.3.8.4. STRATEGIC INITIATIVES
8.3.9. ENZO BIOCHEM INC.
8.3.9.1. COMPANY OVERVIEW
8.3.9.2. FINANCIAL PERFORMANCE
8.3.9.3. PRODUCT BENCHMARKING
8.3.9.4. STRATEGIC INITIATIVES
8.3.10. BD
8.3.10.1. COMPANY OVERVIEW
8.3.10.2. FINANCIAL PERFORMANCE
8.3.10.3. PRODUCT BENCHMARKING
8.3.10.4. STRATEGIC INITIATIVES
著作権 ©2022 無断複写・転載を禁じます
